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Abstract
Over half of antimicrobials ordered at hospital discharge are not optimized, many of
which having longer than necessary durations or inappropriate for the indication.
Unnecessary antimicrobial exposures increase the risks of adverse events, antibiotic
resistance, and Clostridioides difficile infections. However, discharge prescribing often
escapes the purview of inpatient antimicrobial stewardship programs and few interventions have been implemented to optimize antibiotic use during transitions of care
(TOC). Herein, the aim was to highlight critical steps and challenges in the implementation of a TOC antimicrobial stewardship program designed to improve prescribing
at hospital discharge. In a five-hospital health system, a pharmacist-led intervention
was implemented during TOC, with the objective of improving oral antibiotic selection and duration. Among a multidisciplinary team of physicians, case managers,
and nurses, the pharmacists engaged in three strategies: (a) early identification of
patients to be discharged on oral antibiotics; (b) collaborative planning and communication regarding guideline-recommended antibiotic selection and duration; and
(c) facilitation of discharge antibiotic prescription with appropriate stop date. Barriers
to completing the intervention on each patient in this experience included: timely
identification of eligible patients prior to discharge, stewardship periods of reduced
staffing during evenings and weekends, and onboarding of new staff and trainees to
the process. Other major challenges that stewardship and pharmacy departments will
face include adoption of best-practice guidelines for discharge, obtaining support
from local physician champions, extending the intervention to various service lines
and departments with limited resources, and engaging stakeholders to support the
program and intervention. This experience demonstrated that pharmacist-led antimicrobial stewardship at discharge can be successful in both academic and community
settings.
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1

|

B A CKG R O U N D

2 | ANTIBIOTIC PRESCRIBING AT
DISCHARGE: SETTING AND POPULATIONS

Antibiotics offer tremendous benefit to patients with infectious
diseases (IDs) and are among the most commonly prescribed medi-

The culmination of data reporting antibiotic prescribing during TOC are

cines; however, up to 50% of prescriptions are classified as “inap-

largely in the hospital or emergency department settings.19,20 Post-

propriate.”1,2 It is now a national priority to reduce unnecessary

discharge antibiotic therapy is often discordant with recommendations

antibiotic exposure to reduce adverse events and antibiotic resis-

for national and/or institutional guidelines and several authors have

tance.1-5 The 2015 National Action Plan for Combating Antibiotic-

highlighted opportunities to optimize therapy in these settings.8,9,11

resistant Bacteria was developed to address the urgent and serious

Using the Veterans Affairs database, Feller et al21 reported that 20% of

drug-resistant threats with implementation of healthcare policies

patients discharged are prescribed an oral antimicrobial, and 40% of the

2

and collaborative antibiotic stewardship programs (ASP). A major

therapy is administered in the postacute setting. Chavada et al found

goal of the National Action Plan was to reduce inappropriate antibi-

that inappropriate prescribing was driven by excess durations of therapy

otic use by 50% and 20% in outpatient and inpatient settings,

with 71% of patients receiving an antibiotic course in excess of

respectively, by 2020; this had since been updated with a goal to

guideline-recommended length of treatment at discharge; however those

lower overall outpatient antimicrobial dispensing with a focus on

who had active ASP interventions were more likely to receive an appro-

identifying prescribing patterns and unnecessary antibiotics.6 While

priate course.17 In a multicenter cohort study, Vaughn et al11 identified

hospital-based ASP interventions successfully improve inpatient

dramatic variability between hospitals and appropriateness of antibiotic

prescribing practices, these actions may not translate into a reduc-

prescribing for pneumonia and UTI. Respectively, 57% and 39% of

tion of inappropriate prescribing at discharge, highlighting the need

patients with pneumonia or UTI-experienced antibiotic overuse. Subjects

to target transitions of care (TOC).7

who did not experience antibiotic use were more likely to be in an aca-

Antimicrobials prescribed at discharge typically feature exces-

demic center and in hospitals with higher bed capacity.11 In more

sive treatment durations and unneeded broad spectrum of activ-

resource-limited settings, piloting a targeted disease states or population

ity.

8-11

Almost half of hospitalized patients discharged with a

(eg, high risk for readmissions, mortality, or adverse events) could

diagnosis of urinary tract infection (UTI) or pneumonia are subject

increase the likelihood of success in an intervention (Table 1).22 Examples

to antibiotic overuse.

11

Each additional antimicrobial day increases

the risk of medication-related harms such as Clostridioides difficile

of case-based interventions for optimization of antibiotics during TOC
and potential barriers are highlighted in Tables 2 and 3.

infection (CDI) and drug resistance, thus orders during TOC should

Antibiotic consumption metrics used for reporting with hospitalized

be evaluated and entered judiciously.12-14 Prolonged drug expo-

patients in the United States do not include the discharge prescription.

sures can be mitigated through application of evidence that shorter

While capturing this “total course” metric would be complex and difficult

durations of therapy are safer and effective for various common

to standardize, the discharge prescription/duration alone represents

infections. TOC represents an opportune moment to reconcile anti-

about half (or more) of the total antibiotic duration/therapy.8,23 In 2020,

microbial selection, dosage, and duration prior to discharge.

15

As an

antimicrobial stewardship in the ambulatory setting was mandated by

adjunct to standard of care, pharmacist-driven interventions at

the Joint Commission on Accreditation of Healthcare Organizations. The

TOC have reduced hospital readmissions.16 Pharmacists and anti-

timeframe of prescribing antibiotics at discharge can address stewardship

microbial stewards are well-positioned stakeholders in ASP to facil-

in the hospital, postacute care, and ambulatory practice. To gain momen-

itate optimized antimicrobial therapy delivery and improve quality

tum and support in stewarding this period (TOC) of antibiotic prescribing,

of prescribing at discharge.5,17

demonstrating feasible and beneficial ASP interventions is crucial.23

Current experiences in the application of ASP at TOC for
oral antimicrobials are limited. Significant attention and expertise are directed toward outpatient parenteral antimicrobial

2.1

|

Health system experience

therapy with consult teams due to severity of infection and
potential complications. However, far more patients are dis-

The ASP TOC intervention was implemented across a five-hospital

charged with oral antimicrobials, many of which belonging to

health system, to target adults admitted to general and specialty medi-

antimicrobial classes associated with severe adverse events and

cal wards who will be discharged on oral antimicrobial therapy.24 One

subsequent emergency department visits. In recognition of the

hospital was an academic center with a fully decentralized clinical

urgent need to improve antibiotic use across all healthcare

pharmacy practice model, two IDs pharmacy residents and one phar-

settings, the Centers for Disease Control and Prevention recom-

macy fellow. The pharmacy trainees operated under supervision of an

mends implementation of ASP in acute, postacute, and ambula-

IDs preceptor. The four community hospitals had mixed models of

tory settings.4,18 This study describes the basis of ASP during

decentralized and centralized pharmacy staffing (Table S1). Each hos-

TOC and the implementation of a multidisciplinary ASP interven-

pital had dedicated ASP full-time equivalents for pharmacists and/or

tion, and opportunity for pharmacist-involvement, for patients

physicians. The established multidisciplinary ASP in the health system

discharged from general medical units on oral antimicrobials for

used formulary preauthorization, prospective audit, and feedback methods

common infections.

for stewardship activities. Before the intervention, decisions for antibiotic
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Common questions surrounding a transitions of care intervention

FAQ
Where should I start?

An institution or health system wide rollout for all patients discharged on antimicrobials
would be a large undertaking and significant investment of resources. Consider first
assessing where the highest-yield interventions and populations are in the institution
to have a targeted and informed approach. The CDC refers to resources such as a Gap
Analysis Tool (https://www.henryford.com/-/media/files/henry-ford/hcp/
antimicrobial-stewardship-transitions-of-care/amstoc-gapanalysis.pdf?la=en&hash=
16E8888D0FB17BFBE9E70A0B0C1485FF) and education for healthcare
professionals related to antimicrobials at discharge.22 Discussing and reviewing these
checklists with colleagues and collaborators will ensure preparation for an ASP TOC
intervention.

What are some populations of interest to start the
intervention on a smaller scale?

Piloting an intervention with supportive providers and/or on wards with reliable
communication and patient identification strategies will increase the likelihood of
success of the intervention. Some initial approaches could include limited populations:
• Disease state based with clear evidence for short-course durations (eg, CAP, UTI)
• High-risk readmission and polypharmacy (geriatric, high comorbidity scores)
• High risk for antibiotic mismatch (eg, pending microbiologic data, multidrug
resistance)
• Antibiotics with higher toxicity risks (eg, fluoroquinolones, sulfonamides)

What are common antibiotic prescribing errors at
discharge?

One of the most common oversights is lack of consideration of the inpatient duration
into the total antibiotic duration for the discharge prescription. This, in addition to
other “counting errors” such as copying/pasting antibiotic day number, can lead to
excessive durations. Other opportunities also include continued prescribing for
noninfectious indications (such as ASB), incorrect dosages, and inappropriate drug (eg,
fluoroquinolone for uncomplicated cystitis without allergies).

What types of pharmacists were engaged in this
intervention on a day-to-day basis?

• Decentralized unit-based pharmacists involved in the routine care and order
verification are in a prime position to intervene during TOC.
• Outpatient and central pharmacists can improve patient identification and medication
access.
• Pharmacist extenders, including pharmacy residents, students, and other trainees.
• Infectious diseases and antimicrobial stewardship pharmacists.
• TOC pharmacists managing chronic disease states and medication reconciliation.

How can I convince administration and C-suite to
leverage resources to take on discharge prescribing?

Investment in new resources and/or expansion of existing resources is a difficult
decision which requires extensive consideration of financial impact, clinical impact,
return on investment, possible loss of services from other areas. However, ASP TOC
interventions have shown to significantly improve patient safety by reducing
antibiotic durations, excessively broad selection of therapy, and serious adverse
effects. The ASP TOC process can also facilitate conversations about oral therapies
and accurate documentation, which can impact length of stay if the intervention
occurs early in care. Other authors have also identified signals in reduction of
readmissions, which could be leveraged particularly in high-risk populations.

Are there automated/EHR interventions that can improve
prescribing patterns at discharge?

•
•
•
•

Removal of automated durations.
References to guidelines or nudging in the order-entry process.
Review of order sets for inappropriate antibiotics and/or durations.
Streamlining of reports for anticipated discharge to facilitate patient identification.

Abbreviations: ASB, asymptomatic bacteriuria; ASP TOC, antimicrobial stewardship transitions of care program; CAP, community-acquired pneumonia;
CDC, Centers for Disease Control and Prevention; EHR, electronic health record; FAQ, frequently asked questions; TOC, transitions of care; UTI, urinary
tract infection.

selection and duration at discharge were limited to passive interventions

receiving the intervention given limited application of evidence-based

with guidelines and education. Diagnoses of interest targeted common

short-course therapies in these populations.

infections with supporting evidence for criteria-dependent short durations
of therapy, in alignment with health system guidelines (Table S2): UTI,
pneumonia, upper respiratory tract infections, acute exacerbations of
chronic obstructive pulmonary disease, skin/skin structure infections, and

3 | INTERVENTIONS AND PHARMACIST
RO LE I N S T E W A RD S H I P A T TO C

infection of intra-abdominal sites after adequate source control.25 Those
with solid organ or hematopoietic stem cell transplants, and complicated

Pharmacists practicing in antimicrobial stewardship, emergency

infections (eg, prostatitis, empyema, osteomyelitis), were excluded from

department, general medicine, and outpatient settings have played
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TABLE 2

Vignettes for transitions of care cases

Case

Description of case

Action

Result

UTI in an 81-year-old-female

An 81-year-old-female with history
of dementia and CKD presented
with altered mental status,
dysuria, and was started on
ceftriaxone. On hospital day 2
during rounds, the medical
resident is discussing the case
and plan for discharge given her
clinical improvement. Based on
pyuria and urine culture results
ciprofloxacin 500 mg PO twice
daily for 5 days was discussed.

Given this patient's diagnosis
(cystitis), age, and comorbid
conditions, a fluoroquinolone is
not an ideal choice. Based on
guidelines and institutional
recommendations, the
pharmacist recommends one
more of cefpodoxime a total
duration of 3 days. She
improved with ceftriaxone,
which reaches high and
sustained urinary
concentrations. The team and
staff physician agree, and the
inpatient order is placed with a
stop date and the plan is
documented in the progress
note. The pharmacist places the
antibiotic discharge order with
dose and duration for cosign and
leaves documentation in the
EHR with the correlating
regimen.

After rounds, the medical resident
places all other discharge orders.
They cosign the antibiotic order
that was already placed by the
pharmacist. The patient is
discharged with one more day of
renally adjusted cefpodoxime
200 mg PO BID. Early
conversations about discharge
antibiotics were able to help
avoid a fluoroquinolone for an
elderly patient with an
uncomplicated infection. On a
large scale, such interventions
can prevent rare, but serious
adverse events.

Nonpurulent skin/soft tissue
infection in a 63-year-old male

A 63-year-old male with history of
CKD and CHF was admitted
with heart failure exacerbation
and erythema of right lower
limb. The decentralized
pharmacist sees that the patient
is now stable and on day 3 of
vancomycin; a planned discharge
date for today is marked in the
EHR monitoring column. They
review discharge information
and find a pending order for
SMT 2 DS BID for 7 days.

The decentralized pharmacist calls
the team and discusses the
choice of SMT with the medical
resident, given the patient's CKD
and concomitant lisinopril and
spironolactone. The cellulitis has
improved and the suspected
pathogens are streptococci; he
has not failed prior therapies nor
has antibiotic allergies. The team
agrees to a total 5-day course
with an oral beta-lactam. The
pharmacist updates the
discharge regimen. They place a
note in the EHR with the agreed
upon regimen and end date. The
plan in the discharge summary is
appropriately updated.

The provider signs the discharge
order, and the patient is
discharged with cephalexin
500 mg PO TID for two more
days to complete 5 days of
therapy for nonpurulent SSTI. A
longer duration of 2 DS BID
SMT in this specific case may
have resulted in serious renal
injury or electrolyte
disturbances.

CAP in a 57-year-old female

A 57-year-old female with history
of type 2 diabetes and
hypertension is admitted with
fevers, cough, shortness of
breath, diagnosed with CAP.
Ceftriaxone and doxycycline
were started. On day 2 of
hospitalization, she is afebrile,
off supplemental oxygen, and
cultures remain negative. In
discussions at collaborative
rounds, the resident plans to
complete the course with
cefuroxime and doxycycline. The
correct antibiotics are ordered,
but for another 5 days.

The pharmacist brings up the order
that was placed for discharge—
there was miscommunication
between the overnight resident
placing the discharge orders, and
the intention was to account for
the inpatient days as well, for a
total of 5 days. The pharmacist
updates the discharge order and
includes an additional comment
to discharge pharmacy with the
correct antibiotic end datemaking sure to include a single
evening dose of doxycycline
before starting the cefuroxime
the next day (ceftriaxone had
already been administered in the
morning).

The provider signs the order, and
patient is discharged and
educated on taking cefuroxime
500 mg PO BID and doxycycline
100 mg PO BID for a total of
3 days after discharge. Lack of
accounting for inpatient
antibiotic duration is a common
error in discharge prescribing.
Careful review and clear
instructions for stop dates and
progress notes can help mitigate
the additional risks that each
additional antibiotic day may
carry.

Abbreviations: CAP, community-acquired pneumonia; CHF, congestive heart failure; CKD, chronic kidney disease; EHR, electronic health record; SMT,
sulfamethoxazole-trimethoprim; SSTI, skin/soft tissue infection; UTI, urinary tract infection.
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Examples of barriers to ASP during TOC in hospital pharmacy models

Barriers to TOC

Description

Examples of approaches to barriers

Staffing—Extra time and resources
are needed to quickly and
accurately identify patients
approaching discharge, assess
the clinical case, contact/
communicate with the
prescriber/prescribing team,
enter or change order, and
document the plan

• Competing needs such as: order
verification, patient education,
dispensing, management of public
health/outbreak-related responsibilities
• Certain pharmacy practice models, areas
of practice, or units include a higher
patient to pharmacist ratio and/or higher
acuity of patients
• Staff shortages, call-ins or staffing
shortages, redistribution of patient/unit
responsibilities

• Departmental buy-in to have allotted resources for TOC in
clinical pharmacy services. If possible collect preliminary data at
the site to show the need for improvements in safety and
medication errors
• Gain advocacy from prescriber groups with proposal of
additional benefits to improve quality of care during TOC
• Start in a focused/smaller population with high likelihood of
benefit and success
• Collaboration with informative technology services can help
triage and identify patients approaching discharge, optimize
order sets, and remove any inappropriate automated durations
• Partner with the outpatient pharmacies, if on site, to increase
bandwidth in identification of patients
• Implement guidelines with objective criteria for therapies to
streamline evidence-based information for discharge prescribing

• Initiate interventions and communications prior to discharge
• Limited clinical pharmacy services are
Weekends and “off-hours”—
dates
available on the weekends and off-hours
Monitoring prescribing in
• Ensure that documentation from the primary team and
(eg, outside of 0700-1600), which can
periods of unavailability (evening
pharmacist related to antibiotic discharge plan are documented
contribute to missed opportunities in
discharges, discharges during
ahead of time, if discharge over weekend or evening is
optimizing antibiotics during TOC
limited staffing periods)
anticipated
• ASP workflows may not extend beyond
• Use protocolized interpharmacy handoff mechanisms (eg, iweekday shifts or include TOC
Vents in Epic hospitals) to communicate future plans
interventions
• Delegate TOC responsibilities for oral antibiotics to the covering
PharmD/physician if there are mechanisms in place to support
ASP on weekends
Communication—Reduced
information sharing, difficult to
reach prescribers

• Communication between pharmacist and
prescriber can vary based on the practice
model, resources, and hospital type
• The time of day and/or service (eg,
admitting residents or surgical teams in
the operating rooms)
• Paging systems that rely on-call back
may delay communications regarding
antibiotic discharge plans

• Participate in TOC activities during collaborative rounding
periods to involve all parties (nursing, case management,
physicians, nurse practitioners, physician assistants, etc.), if
possible
• Have a protocol in place for designated contacts for each
patient assignment in the prescribing and discharge process
• Promote early implementation and documentation of discharge
plans and orders
• Use secure messaging platforms to confirm antibiotic plans
when paging, rounding, or phone is not possible
• Develop institutional policies and collaborative practice where
discharge orders can be entered (or modified) per protocol for
future cosign for patients who meet strict criteria

• Prescribing inertia may occur, especially • Allow perprotocol modification/entry of discharge antibiotic by
Acceptance and participation—
Obtaining and sustaining buy-in
pharmacist, for future cosign
after antibiotic plans and orders have
and support from individuals and
• Promote multidisciplinary guidelines throughout institution to
already been discussed and entered
the health system
increase comfort of participating in TOC interventions for all
• Burnout and competing priorities can
clinicians
limit the sustainability of an intervention
• Delegate team or unit-based physician champions; consider
obtaining signed letters of support and routine collaborative
meetings related to guidelines, workflows, and challenges
• Communicate that lack of ability to intervene should not delay
discharge; if it better suits the institution, the additional support
from pharmacy should be ancillary rather than required
• Require training programs specific to the institution for
participating pharmacists
• Allow mechanisms for ASP/ID/Medicine leadership involvement
in controversial or difficult cases
• Share positive feedback and success stories with all healthcare
teams
Abbreviations: ASP, antimicrobial stewardship program; ID, infectious diseases; TOC, transitions of care.
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TABLE 4

Examples of antimicrobial stewardship TOC interventions
Discharge assessment
and communication

Action and/or
Documentation

• Manual chart review
at time of discharge
antibiotic entry by
both staff and ASP
pharmacist

• Hospital guidelines
and pocket cards for
discharge therapies
adopted and
reviewed by
pharmacist

• Direct feedback to
primary team at time
of discharge
antimicrobial, when
needed
• Recommendation
acceptance
documented in
standard
reporting form

• Stewardship
Program
• Pharmacy
• Infectious
Diseases
• Family
Medicine

• -ASP pharmacist
contacts primary
team for list of
patients with an
anticipated discharge

• ASP pharmacist
performed
interventions related
to safety, efficacy, or
simplification in
accordance with
institutional
guidelines
• Verbal
communications

• Direct feedback
provided to primary
team prior to
discharge

• Academic center,
adults on general
medicine/surgical
wards

• Stewardship
Program
• Pharmacy

• Manual chart review
by one ASP
pharmacist, triggered
by entry of discharge
antibiotic

• ASP worksheet
including
recommendations
and appropriateness
of discharge
antimicrobial

• Direct feedback
provided to
primary team

Leja et al20

• Academic center,
adults at high risk for
mortality

• Pharmacy
• Stewardship
Program

• TOC pharmacists
used electronic
scoring tool to find
those at high risk for
mortality

• ASP guidelines used
for preferred
antibiotic choices,
doses, durations

• Direct feedback
provided to primary
team, if needed
• Discussion with
patient for
medication
education prior to
discharge when able
• Recommendations
documented in
internal database for
quality improvement

Giesler et al29

• Academic medical
center, adults on
hospitalist service

• Stewardship
Program
• Pharmacy
• Internal
Medicine
• Hospitalists

• Collaborative
pharmacy rounds
with “time-out” prior
to discharge
• Automated page to
covering pharmacist
when a discharge
antibiotic order was
signed

• Institutional
guidelines and
pocket cards for
discharge therapies
adopted and
reviewed by
pharmacists
• Antibiotic timeout
checklist which
included: assessment
of infection,
opportunity for oral
therapy, and
documentation plan
• In-person or phone
communications

• Direct feedback
provided to primary
team prior to, or at
discharge
• Checklist review for
documentation of
dose, indication, and
total planned
duration in discharge
summary

Population

Stakeholders

Patient identification

Yogo et al26

• Academic center,
adults on general
medicine/surgical
wards with CAP,
UTI, or skin/soft
tissue infection

• Stewardship
Program
• Pharmacy
• P&T
Committee
• Clinical
guidelines
committee
• Hospital
Chief Clinical
Officer

Su et al27

• Community teaching
center, adults
discharged on oral or
intravenous antiinfectives from
family medicine
service

Zampino et al28

(Continues)
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(Continued)
Discharge assessment
and communication

Action and/or
Documentation

• Manual chart review
by one adult and one
pediatric ASP
pharmacist, triggered
by entry of discharge
antibiotic

• Discharge
prescriptions
reviewed for drugrelated problems
(dose, duration,
interactions)
• Prescribers
contacted via HIPAA
compliant EHR
messaging

• Direct feedback
provided to
primary team
• Standardized
templates used to
log interventions and
drug-related
problems for quality
improvement
purposes

• Stewardship
Program
• Infectious
Diseases
• Microbiology
• Pharmacy

• Electronic reporting
tool for patients on
antimicrobials
in EHR
• Electronic reporting
tool for patients
discharged with
unresulted culture
data reviewed by
ASP pharmacist

• Criteria for
inappropriate
therapy based on
final microbiologic
result
• Prescribers
contacted by page
and/or phone

• ASP pharmacist
discussed
recommendations
with on-call ID
physician
• If deemed necessary,
prescriber contacted
by ASP/ID to make
change in care

• Stewardship
Program
• Pharmacy
• Internal
Medicine
• Infectious
Diseases
• Family
Medicine
• Hospitalist
• Nephrology
• Cardiology
• Pulmonology
• Nursing
• Case
management

• Anticipated
discharges discussed
at collaborative
• EHR column flag and
progress note review
for anticipated
discharge
• Communication from
case management
reports for
anticipated discharge
• Communication from
the outpatient
pharmacy at time of
discharge order

• Institutional
guidelines reviewed
by pharmacists and
primary team
• In-person, verbal, or
remote/ paging
communication
depending on
hospital model and
staffing

• Direct feedback
provided to
primary team
• Discharge order
entered for cosign if
none present
• Discharge order
edited as needed if
already entered
• Discharge antibiotic
plan documented in
medical chart note

Population

Stakeholders

Patient identification

Parsels et al30

• Academic medical
center, patients with
any oral
antimicrobial
prescriptions sent to
the hospital
outpatient pharmacy

• Stewardship
Program
• Pharmacy

Jones et al19

• Academic medical
center, adults
discharged on an oral
antimicrobial with
unresulted
culture data

Henry Ford
Health System
Experience24,31

• One academic and
four community
centers, adults
prescribed oral
antibiotics for
respiratory, urinary,
intra-abdominal, and
skin-soft tissue
infections

Abbreviations: ASP, antimicrobial stewardship program; CAP, community-acquired pneumonia; EHR, electronic health record; HIPPA, The Health
Insurance Portability and Accountability Act; ID, infectious disease; P&T, pharmacy and therapeutics; TOC, transitions of care.

essential roles in ASP during TOC (Table 4).19,20,24,26-31 Workflows

the prescriber, when needed, facilitates optimal antimicrobial

and checklists for pharmacists were integrated into multiple ASP TOC

courses.30 Direct entry of prescription by pharmacist into electronic

care models. A common approach for antimicrobial review is providing

discharge medication queues for cosign is another strategy which

audit and feedback in real-time once a prescription has been entered

takes on more active role, and also offsets workload from primary

or signed. A limitation of this strategy is that a prescriber may be less

teams.24 Some hospitals with existing structures for TOC pharmacists

likely to adjust or modify an order that has already been processed or

were able to provide additional patient education about their

filled. Working closely with the outpatient pharmacy, case manage-

antibiotic course and administration instructions.20

ment, and the primary team will also improve the accuracy of an anticipated discharge. Discussed in greater detail below, pharmacists can
be involved with early patient identification—this approach is more
resource intensive but may capture more patients. Often, the inter-

3.1 | Health system experience: Patient
identification and pharmacist role

vention type and acceptance rate are documented by the pharmacist
as a quality improvement metric. Development of local guidelines

Pharmacists across the health system were responsible for identifying

along careful oversight of order sets can promote best practices in dis-

patients with active antimicrobial therapy for infections that may be

charge antimicrobials—particularly, in disease states with an evidence

eligible for oral therapy for discharge. Using Epic as the electronic

base for short-course therapy.26 Communicating recommendations to

health record (EHR), pharmacists assessed patients' clinical stability,
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infection type, and potential discharge barriers (Figure S1). The phar-

licensed prescriber. The final antimicrobial regimen was documented

macist communicated with the provider via phone, page, or in-person

in a short note in the EHR by the pharmacist, and patients were edu-

depending on the pharmacy practice model and unit at the respective

cated on antimicrobial safety and administration by a licensed nurse

hospital. Once the discharge antibiotic selection, dose, and duration

or pharmacist prior to discharge.

were agreed upon, the pharmacist entered the discharge order in the
EHR per protocol, with an additional note on the appropriate end
date, to be signed by the provider. The pharmacist could also send an

3.1.2

|

Community hospital experience

electronic discharge medication cost inquiry to the discharge pharmacy queue to review medication coverage and copayments prior to

TOC interventions for oral antimicrobials at discharge in the commu-

placing the discharge order.32 A note was then placed in the EHR by

nity hospitals were completed by an ASP pharmacist or delegated

the pharmacist as a plan of care document, describing the discharge

general medicine pharmacists who underwent appropriate training.

antimicrobial regimen and end date.

Each general medicine pharmacists at the community hospitals typically cover 50 to 60 patients. The target population of patients
resided in both location-based prescriber models (ie, prescribers prac-

3.1.1

|

Academic medical center experience

ticing on a single floor/unit) (two hospitals) and team-based models
(prescribing teams managing hospitalized patients regardless of unit/

In the academic hospital, decentralized pharmacists practicing on the

floor location). In the location-based models, areas of high-volume dis-

general medical units participated in daily collaborative rounds where

charge antimicrobials were targeted, such as general and surgical med-

readiness for discharge and potential discharge barriers were dis-

ical units. For team-based models (nonlocation-based), hospitalist and

cussed with physicians, nurses, case managers, and other healthcare

academic teams were selected, and identified in ASP workflow

providers at the front line of patient care. Each pharmacist typically

through an electronic report/column in the EHR. In community hospi-

cared for an estimated 40 patients. The academic units comprised the

tals that did not have a consistent model for pharmacist rounding,

initial intervention rollout (Phase 1) and half of second rollout (Phase

other mechanisms such as notification from case management or the

2) (Figure S2). Hospital team structures and responsibilities to patients

outpatient pharmacy were used to assist in patient identification. The

were location-based, in alignment with the service. Pharmacy respon-

IDs physician played a crucial role, as many patients meeting criteria

sibilities included a focus on TOC, specifically on optimizing medica-

for the TOC intervention in community hospitals also had active ID

tion management and patient education at discharge. Collaborative

consults.

rounds created opportunities for early patient identification for dis-

Interprofessional communication was primarily pager-based. After

charge, interventions with the team, discussion of TOC, and confirma-

discussion with the provider and finalization of the antibiotic plan, an

tion of medication access. Education for rotating residents and

optimized order was placed in the discharge queue to be signed by a

students was routine on internal medicine wards. Certain floors had

licensed prescriber. Like the academic model, in cases where the dis-

pharmacy residents and students who would participate on teaching

charge prescription had already been ordered, the ASP pharmacist

rounds and in discussions on antimicrobial discharge regimens. As

communicates with the outpatient pharmacy to adjust the order, if

pharmacy extenders, they assisted the team and unit-based pharma-

appropriate, after confirming with the provider. The final antibiotic

cists with discharge planning and the ASP TOC intervention. In addi-

therapy, indication, dose, and duration were documented in a short

tion, antimicrobial stewardship staffing occurred between 8

note in the EHR by the pharmacist.

AM

and

5 PM during the week. Weekend coverage for stewardship was staffed
by trainees in IDs pharmacotherapy, one fellow and two residents.
They managed the ASP TOC interventions on the weekends due to
reduced clinical pharmacy services by the unit-based pharmacists.

4 | IMPL EM ENT A TIO N AND L E A DE RSHIP
IN A TOC MODEL

Electronic patient reports containing columns with antimicrobial
information and anticipated discharge dates were also added to

The case for improving patient safety with interventions at TOC con-

patient care lists in the EHR in the attempt to identify candidates early

tinues to grow. Impactful interventions that are feasible, practical, and

in the admission. Pharmacists opened an electronic handoff communi-

nonresource intensive are of highest value to both ASPs and health

cation (i-vent) in the EHR as a handoff mechanism for flagging TOC

system administrators. Antimicrobial stewardship interventions during

opportunities for patients that may be soon discharged. Once patients

TOC are associated with reduced antibiotic-related adverse effects

were identified as “possible discharge,” antibiotic therapy and dura-

and readmissions; however, treatment-related effects on such out-

tion was discussed during collaborative rounds. End dates were

comes are generally multifactorial and confounded, and these results

encouraged to be added to the inpatient antibiotic orders and an elec-

have only been demonstrated in nonrandomized study settings to

tronic tool in the EHR was used to communicate discharge medication

date.20,31 Conducting medication-use evaluations to identify opportu-

cost and accessibility. The antimicrobial orders for discharge were

nities specific to the health system can increase the likelihood of suc-

placed in the EHR with appropriate selection, dose, and end dates

cess and uptake of a pilot study/intervention. Process endpoints such

concordant with institutional practice guidelines, and then signed by a

as duration of therapy and antimicrobial selection continue to serve as
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quality improvement metrics in ASP and surrogates for safety

39.5% of eligible patients with antimicrobials sent to the outpatient

measures.

discharge pharmacy and notified providers in 10.8% of cases for

Broad engagement with all stakeholders is crucial for the success

guideline-discordant regimens. While the total number of fluoroquino-

of any intervention that can impact thousands of patients annually.

lone prescriptions and duration of discharge prescription was reduced,

Peer comparison and letters of commitment are behavioral interven-

there was no significant difference in inappropriate prescribing, total

tion strategies that have improved antimicrobial prescribing in

duration of therapy, or adverse drug events; however only 7.2% of

33,34

clinics.

Historically, key collaborators in ASP TOC interventions

antibiotics prescribed at discharged had dose, selection, or duration

include, but are not limited to: pharmacists, Pharmacy and Therapeu-

optimized from the intervention.26 Zampino et al expanded ASP ser-

tics (P&T) Committees, IDs, internal medicine, hospitalist groups, fam-

vices for discharge antibiotic from medical/surgical wards by having

ily medicine, nursing, case management, and so forth (Table 4).

an ASP pharmacist provide audit and feedback at the time of discharge. Even when the discharge prescriptions have already been
entered and ordered, this program was able to improve appropriate-

4.1

|

ness of therapy from 47.5% to 85.2%.28 On a statewide scale, Vaughn

Health system experience

et al directed 41 centers in Michigan in an intervention for reporting
Metrics on health system antibiotic discharge prescribing were pres-

and benchmarking antibiotic prescribing for community-acquired

ented to the system ASP, which prompted the need for review of

pneumonia. Over the study period, duration of antibiotic and fre-

antibiotics prescribed during TOC. Specifically, the frequency of incor-

quency of adverse events decreased.36 The clinical impact on safety

rect prescribing of fluoroquinolones and local trends in antibiotic-

and patient-centered outcomes will prove to be critical in future

related adverse events were highlighted as opportunities for quality

efforts in advocacy for ASP TOC support, with authors reporting

improvement.35 The TOC protocol was approved and rolled-out

improvements in quality or prescribing, adverse events, and even

sequentially in academic and community hospitals every 3 months fol-

possibly readmissions.28,31,36

lowing extensive training of all healthcare providers involved. The

In a mixed-method approach, Giesler et al reviewed process out-

selection and order of intervention implementation for each hospital

comes to describe impact of a pilot TOC intervention on antimicrobial

and unit was generally based on “readiness,” which required available

use at discharge following “timeouts” on a hospitalist floor. The

resources, education, broadcasting, and staffing. Educational materials

authors also assessed the feasibility, acceptability, adherence, and

and workflow guidance were available electronically and on pocket

awareness surrounding the intervention. Most pharmacists and

cards for pharmacists (Figure S1) as well. Pharmacists were required

hospitalists described the intervention feasible and helpful, and found

to attend an ASP TOC training seminar to exercise the protocol in the

that it improved patient care (79%).29 Each patient intervention was

health system. Nursing units, resident conferences, and specialty

an additional 5 min to the pharmacists' workflow, however, could be

groups were introduced to the protocol and lead physicians were

up to 20 min if the discharge prescription had already been signed

appointed on different wards. Letters of support were drafted and

and sent to the pharmacy prior to communication with a team.29

signed by stakeholders in the Departments of Pharmacy, Internal

Parsels et al also found a high frequency of intervention acceptance

Medicine,

Diseases,

(76%) using a model involving patient identification from the hospital

Nephrology, Cardiology, Hospitalist, and Family

outpatient pharmacy, to the ASP pharmacist, who made further rec-

Antimicrobial

Pulmonology,

Stewardship,

Infectious

Medicine.

ommendations to the primary team when needed. When the interventions were accepted, the antibiotic duration decreased by 4 days on
average; interventions generally required less than 15 min.30 These

5 | M E A S U R I N G SU C C E S S E S A N D
C HA L L E N G E S I N A TO C M O D E L

are key datapoints in implementation science to quantify intervention
uptake, sustainability, and monitoring of intervention success.

Monitoring the successes and challenges following implementation
provides transparency related to the quality, sustainability, and bar-

5.1

|

Health system experience

riers to the progress of the intervention. Both clinical and quality
metrics are important to collect and disseminate among stakeholders.

Multiple mechanisms of monitoring were in place to sustain quality

Su et al27 and colleagues implemented a pharmacist review of antimi-

improvement of the intervention and provide continued feedback

crobials at TOC from a family medicine service and identified a preva-

to end-users. A poster was displayed in the hospital pharmacy to

lence of 42% in medication errors among 45 discharged patients, in

report the number of patients impacted by the intervention, the

which 13 errors were avoided. The study was noncomparative and

percentage of interventions completed on eligible patients (proto-

was unable to evaluate impact on clinical outcomes, and the investiga-

col adherence) and photographs of key stakeholders. The poster

tors described the intervention as difficult to sustain and resource

was updated each month and information was disseminated to the

26

used institutional guidelines, tools, and inter-

pharmacists. To monitor the quality of intervention uptake and pro-

vention to improve quality of prescribing at TOC for patients receiving

tocol adherence, 25 eligible patients were randomly screened each

oral antibiotics for respiratory, skin, and UTIs. Pharmacists reviewed

month when the intervention was in place. Adherence to protocol

intensive. Yogo et al
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F I G U R E 1 Interventions
completed and percent of
interventions completed on
eligible subjects by month and
study period

was defined as documentation in the EHR by pharmacist of an oral

6

|

DI SCU SSION

antimicrobial discharge plan (antimicrobial dose, duration, and
selection based on institutional guidelines with authorizing pre-

This intervention describes a pharmacy practice model shift focused

scriber). Root-cause analyses of nonadherent and nonguideline

on antimicrobial selection and duration at transition of care that can

concordant cases were also intermittently reviewed to target areas

serve thousands of patients annually across a health system. Imple-

or groups in need for quality improvement. Challenges and

mentation science was applied to support optimal uptake of the inter-

guideline-discordant cases were encouraged to be shared with the

vention at TOC. First, prescribing of broad-spectrum antimicrobials at

physician and pharmacist principal investigators to undergo peer

discharge in the health system was examined. Fluoroquinolone indica-

review. Every quarter, an “open-house” was held where stake-

tions and durations were often not concordant with recommended

holders were invited to attend a presentation on TOC intervention

practice guidelines.9 Target units for implementation with high vol-

progress with lunch and questions.

umes of antimicrobial prescriptions at discharge were identified, at

The ASP TOC intervention was implemented across five hospi-

which point physician and pharmacist champions were assigned to be

tals on 18 distinct units and provider teams (Figure S2). Over this

responsible for communications and training. Similar methods were

period, we were able to optimize the discharge antibiotics of over

used intermittently throughout the study implementation to dissemi-

1500 patients (Figure 1). The overall protocol adherence during this

nate protocol adherence including: notifications from study investiga-

time was 63%, sustained over a 9-month period.31 Adherence in

tors, commitment letters, and posters that tracked total number of

the first phase (academic center) was 70%, 61% in the second (aca-

interventions and protocol adherence every month for each study

demic and community centers), and 44% in the third (community

phase. Pharmacists and providers were not individually notified but

centers) (Figure 1). All cases were reviewed for possible qualities

addressed as teams for each service line.

associated with nonadherence including: discharges on weekends

The most successful models, by protocol adherence, implemented

prescribing (17%), and admissions <24 h

the ASP TOC service in adjunct with collaborative rounds, clinical

(8%). Despite this, the intervention was completed in 70% and 46%

rounds, and face-to-face communications. Each point of contact

of subjects among eligible in the academic and community hospital

offered opportunities to intervene at TOC. It was advantageous to

models, respectively. By service line, protocol adherence was as

have multiple disciplines involved in the intervention at time of dis-

follows:

64%;

charge planning to coordinate care; this allowed pharmacists to easily

Pulmonology, 76%; Hospitalist, 73%; Infectious Diseases, 79%;

“queue-up” an electronic discharge order for a prescriber to review

Cardiology, 59%; Nephrology, 68%. Following the implementation

and cosign. Orders that were already entered could be edited if it

of the intervention, the frequency of optimal antibiotic course

were determined that an adjustment would not lead to delays in

received at discharge increased from 36% to 81.5%; the discharge

patient discharge. Collaboration with the institutions' outpatient phar-

antibiotic duration was reduced from 4 (interquartile range [IQR],

macy facilitated communication and medication access between the

(18%), postcall (after 5

Family

PM)

Medicine,

71%;

31

Internal

Medicine,

There was no difference in clinical

inpatient team. These models were also able to incorporate learners

success, hospital readmissions, or mortality, however, incidence of

such as residents, fellows, and students to conduct interventions

serious antibiotic-related adverse events was reduced.31

under the supervision and license of another healthcare professional.

3-5) days to 3 (IQR, 2-4) days.
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One of the major challenges for the TOC models that did not rely

• Create mechanisms to identify patients approaching hospital dis-

on a rounding clinical pharmacist or collaborative rounds was the
difficulty in the identification of patients approaching their discharge

charge and prospectively validate the tool.
• Share progress, expectations, and successes with all groups

date. Multiple strategies attempted to remotely identify patients

involved.

approaching discharge including collaboration with case management
to send discharge reports to pharmacists and developing a tool for
provider-initiated reporting of anticipated discharge dates into Epic

7

|

CONC LU SION

columns. However, the columns were frequently invalid and patients
identified by case managers with orders for discharge often already

Thousands of patients are discharged from health systems with

had antimicrobial discharge orders prescribed. Thus, additional steps

antimicrobials annually, representing a critical opportunity for ASP.

were taken to optimize the outpatient prescription when deemed nec-

There are many approaches to implementing a model for ASP dur-

essary to change. In resource-limited settings there may be other

ing TOC. Key steps include development of guidelines, gaining

interventions with possible “low effort/high impact,” depending on

support from stakeholders, establishing a reliable system for

clinical workflow for entry of discharge prescriptions. Automatic gen-

patient identification, collaborative planning, communication, and

eration of a fixed duration (eg, levofloxacin for 5 days) will likely result

ensuring accurate documentation of a plan. We observed

in an excessive course, given these electronic orders usually cannot

sustained pharmacist-driven interventions in a practice model

account for the therapy duration received in the hospital. Careful

change aimed to improve antimicrobial prescribing at TOC. Careful

review of all order sets, methods, and practices associated with entry

implementation of training, procedures, communication, and

of discharge prescriptions can identify opportunity for intervention

monitoring is necessary to support successful and sustainable

from EHR/information technology support.23 Adaptation of hospital

large-scale interventions.

guidelines for antimicrobial selection, dosage, and duration for incorporation into discharge workflows is also a key component in many
29,31

interventions, as a supplement to audit and feedback.
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